Nothing Special   »   [go: up one dir, main page]

NO20012152D0 - Materiale for hemming av proliferasjon av celler, og fremgangsmåte til fremstilling av samme, og anvendelse derav - Google Patents

Materiale for hemming av proliferasjon av celler, og fremgangsmåte til fremstilling av samme, og anvendelse derav

Info

Publication number
NO20012152D0
NO20012152D0 NO20012152A NO20012152A NO20012152D0 NO 20012152 D0 NO20012152 D0 NO 20012152D0 NO 20012152 A NO20012152 A NO 20012152A NO 20012152 A NO20012152 A NO 20012152A NO 20012152 D0 NO20012152 D0 NO 20012152D0
Authority
NO
Norway
Prior art keywords
cell proliferation
producing
same
inhibiting cell
compositions
Prior art date
Application number
NO20012152A
Other languages
English (en)
Other versions
NO20012152L (no
Inventor
Shirin Asina
Kanti Jain
Albert L Rubin
Barry Smith
Kurt Stenzel
Original Assignee
Rogosin Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rogosin Inst filed Critical Rogosin Inst
Publication of NO20012152D0 publication Critical patent/NO20012152D0/no
Publication of NO20012152L publication Critical patent/NO20012152L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20012152A 1998-11-09 2001-05-02 Materiale for hemming av proliferasjon av celler, og fremgangsmåte til fremstilling av samme, og anvendelse derav NO20012152L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/188,476 US6224912B1 (en) 1996-04-03 1998-11-09 Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
PCT/US1999/026413 WO2000027207A1 (en) 1998-11-09 1999-11-09 Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof

Publications (2)

Publication Number Publication Date
NO20012152D0 true NO20012152D0 (no) 2001-05-02
NO20012152L NO20012152L (no) 2001-07-05

Family

ID=22693322

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20012152A NO20012152L (no) 1998-11-09 2001-05-02 Materiale for hemming av proliferasjon av celler, og fremgangsmåte til fremstilling av samme, og anvendelse derav
NO20101615A NO20101615L (no) 1998-11-09 2010-11-17 Materiale for hemming av proliferasjon av celler, og fremgangsmate til fremstilling av samme, og anvendelse derav.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20101615A NO20101615L (no) 1998-11-09 2010-11-17 Materiale for hemming av proliferasjon av celler, og fremgangsmate til fremstilling av samme, og anvendelse derav.

Country Status (19)

Country Link
US (4) US6224912B1 (no)
EP (1) EP1128731B1 (no)
JP (2) JP4294223B2 (no)
KR (3) KR20050055797A (no)
CN (1) CN1325271A (no)
AT (1) ATE446678T1 (no)
AU (1) AU769411B2 (no)
CA (1) CA2334483C (no)
DE (1) DE69941599D1 (no)
DK (1) DK1128731T3 (no)
EG (1) EG24212A (no)
ES (1) ES2335723T3 (no)
HK (1) HK1039439A1 (no)
IL (3) IL139704A0 (no)
NO (2) NO20012152L (no)
NZ (1) NZ511220A (no)
PT (1) PT1128731E (no)
RU (2) RU2268735C1 (no)
WO (1) WO2000027207A1 (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ329619A (en) * 1994-01-13 1999-09-29 Rogosin Inst Use of macroencapsulated secretory cells in agarose coated collagen gel material to treat diseases related to secretory cell failure
USRE39542E1 (en) * 1994-01-13 2007-04-03 The Rogosin Institute Preparation of agarose coated, solid agarose-collagen beads containing secretory cells
US6224912B1 (en) * 1996-04-03 2001-05-01 The Rogo Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
US7297331B2 (en) * 1996-04-03 2007-11-20 The Rogosin Institute Beads containing restricted cancer cells producing material suppressing cancer cell proliferation
US20050053586A1 (en) * 2003-09-04 2005-03-10 Bryan Conn Entrapped stem cells and uses thereof
WO2006053052A2 (en) * 2004-11-11 2006-05-18 The Rogosin Institute Method for treating patients with implants of islets which have been kept in long term, in vitro culture
ES2379008T3 (es) * 2005-09-26 2012-04-19 The Rogosin Institute, Inc. Macroperlas que contienen células secretoras que comprenden agarosa Seakem Gold, y sus usos
EP2063239A4 (en) 2007-06-08 2013-12-25 Hamamatsu Photonics Kk SPECTROSCOPIC MODULE
US8031336B2 (en) 2007-06-08 2011-10-04 Hamamatsu Photonics K.K. Spectroscope
JP4891840B2 (ja) 2007-06-08 2012-03-07 浜松ホトニクス株式会社 分光モジュール
US8049887B2 (en) 2007-06-08 2011-11-01 Hamamatsu Photonics K.K. Spectroscopic module
JP4891841B2 (ja) 2007-06-08 2012-03-07 浜松ホトニクス株式会社 分光モジュール
JP4887221B2 (ja) 2007-06-08 2012-02-29 浜松ホトニクス株式会社 分光モジュール
EP2072978A4 (en) 2007-06-08 2014-01-08 Hamamatsu Photonics Kk SPECTROSCOPIC MODULE
JP2010536373A (ja) 2007-08-23 2010-12-02 イントレキソン コーポレーション 疾患を診断するための方法および組成物
JP2010540534A (ja) 2007-09-28 2010-12-24 イントレキソン コーポレーション 生体治療分子の発現のための治療遺伝子スイッチ構築物およびバイオリアクター、ならびにその使用
CN102628711B (zh) 2008-03-04 2016-01-20 浜松光子学株式会社 分光模块
JP5205241B2 (ja) 2008-05-15 2013-06-05 浜松ホトニクス株式会社 分光モジュール
JP5205240B2 (ja) 2008-05-15 2013-06-05 浜松ホトニクス株式会社 分光モジュールの製造方法及び分光モジュール
JP5415060B2 (ja) 2008-05-15 2014-02-12 浜松ホトニクス株式会社 分光モジュール
JP5205238B2 (ja) 2008-05-15 2013-06-05 浜松ホトニクス株式会社 分光モジュール
JP5512961B2 (ja) 2008-05-15 2014-06-04 浜松ホトニクス株式会社 分光モジュール及びその製造方法
JP5207938B2 (ja) 2008-05-15 2013-06-12 浜松ホトニクス株式会社 分光モジュール及び分光モジュールの製造方法
JP2009300418A (ja) 2008-05-15 2009-12-24 Hamamatsu Photonics Kk 分光モジュール
EP2412800A1 (en) * 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Liver organoid, uses thereof and culture method for obtaining them
US8572921B2 (en) * 2009-03-27 2013-11-05 Davinci Roofscapes, Llc One piece hip and ridge shingle
EP3228629A1 (en) * 2010-06-16 2017-10-11 Minerva Biotechnologies Corporation Reprogramming cancer cells
KR20190027969A (ko) * 2010-08-12 2019-03-15 얀센 바이오테크 인코포레이티드 췌장 내분비 전구 세포를 이용한 당뇨병의 치료
JP5899230B2 (ja) * 2010-11-23 2016-04-06 ザ・ロゴシン・インスティテュート・インコーポレイテッド 潜在的治療薬をスクリーニングするため、幹細胞様特性を有する癌細胞を単離するため、アガロース内にカプセル化されアガロースでコーティングされた癌細胞を使用する方法、及び本方法により得られる細胞
AP2014007623A0 (en) 2012-01-31 2014-05-31 Rogosin Inst Improved method for manufacture of macrobeads
CN108780094B (zh) 2016-01-12 2022-09-13 生物蛋白有限公司 使用条件活性抗体的诊断方法
US10697972B2 (en) 2016-01-12 2020-06-30 Bioatla, Llc Diagnostics using conditionally active antibodies
KR200485213Y1 (ko) 2016-11-02 2017-12-07 고수한 높이 조절이 가능한 조립식평상
JP2021511790A (ja) * 2018-02-02 2021-05-13 ウェイク・フォレスト・ユニバーシティ・ヘルス・サイエンシーズＷａｋｅ Ｆｏｒｅｓｔ Ｕｎｉｖｅｒｓｉｔｙ Ｈｅａｌｔｈ Ｓｃｉｅｎｃｅｓ 免疫療法に関するオルガノイドならびにそれを調製および使用する方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3865689A (en) 1972-11-09 1975-02-11 Hoffmann La Roche Method of producing carcinoembryonic antigens
US4285930A (en) 1977-12-08 1981-08-25 Likhite Vilas V Antigens comprising immunostimulant adjuvants and their use in immunotherapy
US4409331A (en) 1979-03-28 1983-10-11 Damon Corporation Preparation of substances with encapsulated cells
US4352883A (en) 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US4391909A (en) 1979-03-28 1983-07-05 Damon Corporation Microcapsules containing viable tissue cells
DE3032931C2 (de) 1980-09-02 1982-07-29 Robert Bürkle GmbH & Co, 7290 Freudenstadt Verfahren und Anordnung zur Herstellung von Mehrschicht-Leiterplatten
SE441009B (sv) 1982-03-08 1985-09-02 Kjell Nilsson Sett att immobilisera levande biomaterial i perlformiga polymerer
US4798786A (en) 1982-05-06 1989-01-17 Stolle Research And Development Corporation Living cells encapsulated in crosslinked protein
JPS5933223A (ja) 1982-08-20 1984-02-23 Koken Kk 人の悪性腫瘍細胞増殖抑制剤
CA1196862A (en) 1983-06-01 1985-11-19 Anthony M.F. Sun Microencapsulation of living tissue and cells
US4663286A (en) 1984-02-13 1987-05-05 Damon Biotech, Inc. Encapsulation of materials
US4680174A (en) 1984-05-24 1987-07-14 Damon Biotech, Inc. Induction of immune response by immunization with encapsulated antigen-producing cells
JPS6118721A (ja) 1984-07-06 1986-01-27 Kyowa Hakko Kogyo Co Ltd 新規抗腫瘍性物質
US4997443A (en) 1985-08-26 1991-03-05 Hana Biologics, Inc. Transplantable artificial tissue and process
US4902295A (en) 1985-08-26 1990-02-20 Hana Biologics, Inc. Transplantable artificial tissue
US5618715A (en) 1985-12-20 1997-04-08 Oncogen Limited Partnership Oncostatin M and novel compositions having anti-neoplastic activity
SE8604684L (sv) 1986-11-03 1988-05-04 Excorim Kommanditbolag Sett att belegga fasta partiklar med en hydrofil gel samt genom settet belagda partiklar
JPS6463395A (en) 1987-05-04 1989-03-09 Oncogen Oncostatin m and novel composition having antitumor activity
JPH0216994A (ja) 1988-07-05 1990-01-19 Nippon Mining Co Ltd 細胞増殖阻害因子及びその製造方法
US5053332A (en) 1989-07-24 1991-10-01 Cook Richard B Agarose beads, preferably incorporating biological materials
US5227298A (en) 1990-08-17 1993-07-13 The Trustees Of Columbia University In The City Of New York Method for microencapuslation of cells or tissue
US5800829A (en) 1991-04-25 1998-09-01 Brown University Research Foundation Methods for coextruding immunoisolatory implantable vehicles with a biocompatible jacket and a biocompatible matrix core
JP4215273B2 (ja) 1991-04-25 2009-01-28 ブラウン ユニヴァーシティ リサーチ ファンデーション 選択された治療物質放出用の移植可能で生体適合性の免疫遮断性ビークル
US5643589A (en) * 1992-12-04 1997-07-01 Chalmers; Susanna Elizabeth Desiccant formulated for treating wounds or lesions
DE69430824T2 (de) 1993-08-12 2003-01-23 Neurotech S.A., Evry Biokompatible immunoisolatorische Kapseln, die genetisch veränderte Zellen enthalten
NZ329619A (en) * 1994-01-13 1999-09-29 Rogosin Inst Use of macroencapsulated secretory cells in agarose coated collagen gel material to treat diseases related to secretory cell failure
CN1157560A (zh) 1994-07-08 1997-08-20 巴克斯特国际有限公司 用于治疗癌症的装载有肿瘤细胞的可植入装置
US6224912B1 (en) * 1996-04-03 2001-05-01 The Rogo Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
US5888497A (en) * 1996-04-03 1999-03-30 The Rogosin Institute Agarose coated agarose beads containing cancer cells that produce material which suppresses cancer cell proliferation
ATE374034T1 (de) 1996-04-03 2007-10-15 Rogosin Inst Konditioniertes medium und diffusionsfähiges biologisches material gewonnen durch inkubierung von eingeschlossenen zellen

Also Published As

Publication number Publication date
DE69941599D1 (de) 2009-12-10
US20030143281A1 (en) 2003-07-31
IL139704A (en) 2006-12-31
WO2000027207A8 (en) 2000-09-21
DK1128731T3 (da) 2010-01-25
RU2268735C1 (ru) 2006-01-27
ES2335723T3 (es) 2010-03-31
US7041504B2 (en) 2006-05-09
NO20101615L (no) 2001-07-05
JP4294223B2 (ja) 2009-07-08
US6808705B2 (en) 2004-10-26
EP1128731A1 (en) 2001-09-05
US20020168415A1 (en) 2002-11-14
RU2004115040A (ru) 2005-10-27
KR20050055797A (ko) 2005-06-13
KR20040075922A (ko) 2004-08-30
KR20020013465A (ko) 2002-02-20
ATE446678T1 (de) 2009-11-15
IL139704A0 (en) 2002-02-10
HK1039439A1 (zh) 2002-04-26
RU2236855C2 (ru) 2004-09-27
JP2002529060A (ja) 2002-09-10
EG24212A (en) 2008-10-28
IL177967A0 (en) 2006-12-31
EP1128731B1 (en) 2009-10-28
US6818230B2 (en) 2004-11-16
EP1128731A4 (en) 2003-06-04
WO2000027207A1 (en) 2000-05-18
PT1128731E (pt) 2010-02-02
IL177967A (en) 2010-12-30
US20030143739A1 (en) 2003-07-31
CN1325271A (zh) 2001-12-05
AU1472600A (en) 2000-05-29
US6224912B1 (en) 2001-05-01
NO20012152L (no) 2001-07-05
JP2005343899A (ja) 2005-12-15
CA2334483A1 (en) 2000-05-18
AU769411B2 (en) 2004-01-29
CA2334483C (en) 2012-01-10
NZ511220A (en) 2003-12-19

Similar Documents

Publication Publication Date Title
NO20101615L (no) Materiale for hemming av proliferasjon av celler, og fremgangsmate til fremstilling av samme, og anvendelse derav.
CA2291222A1 (en) Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation
WO1998025598A3 (en) Methods and pharmaceutical compositions for inhibiting tumour cell growth
CA2308177A1 (en) Intravascular stent and method for manufacturing an intravascular stent
WO1998007830A3 (en) COMPLETE GENOME SEQUENCE OF THE METHANOGENIC ARCHAEON, $i(METHANOCOCCUS JANNASCHII)
AU7585598A (en) Raf kinase inhibitors
TR199701574T2 (xx) �midazol bile�imleri
AP2001002225A0 (en) 1-heterocycle substituted diarylamines.
NO975557L (no) Immortalisering og dissimortalisering av celler
IT1286916B1 (it) Procedimento di composizione di numero di radiotelefono mobile.
GB9003939D0 (en) Sulphatase inhibitors
TR199801954T2 (xx) Eprosartan dihidrat ve �retimi ve form�lasyonu i�in bir proses.
IL142720A0 (en) Water-miscible pharmaceutical compositions of paclitaxel
HUP0002921A3 (en) Cyanoguanidines as cell proliferation inhibitors, process for producing them and pharmaceutical compositions containing them
WO2003024405A3 (en) Methods and compositions for inhibiting the proliferation of prostate cancer cells
ATE347741T1 (de) Substratgestützte elektroden-elektrolyt-einheit
IT1194148B (it) Enzimi fibrinolitici,procedimenti per la loro produzione e composizioni farmaceutiche che li contengono
WO1998028299A3 (en) Imidazopyridazines
AU4859399A (en) Compositions and methods for treating papillomavirus-infected cells
AU2001294636A1 (en) Compositions comprising lignin and methods of making and using the same
WO2000040752A3 (en) Cancer associated genes and their products
WO2000021996A3 (en) Methods and compositions for inhibiting neoplastic cell growth
ES1016923U (es) Modulo perfeccionado para galerias de servicios.
BR9611482A (pt) Atribuição de frequência em uma rede de telecomunicação celular
MX9709783A (es) Inmortalizacion y desinmortalizacion de celulas.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application